1RC.F CREO MEDICAL GRP LS-001
- Market cap
- -
- P/E
- -
- P/B
- 0.97x
- ROE
- 10.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 1RC.F undervalued?
Graham numberThe Graham number of CREO MEDICAL GRP LS-001 cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CREO MEDICAL GRP LS-001 fundamental analysis
No fundamental analysis for CREO MEDICAL GRP LS-001 yet.
CREO MEDICAL GRP LS-001 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
CREO MEDICAL GRP LS-001 financial statements
CREO MEDICAL GRP LS-001 annual financial statements (GBP; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 25.2M | 27.2M | 4.00M | 4.00M | 6.00M |
| Gross Profit | 11.6M | 13.2M | 2.30M | 1.90M | 2.40M |
| Operating Income | -29.9M | -30.7M | -26.9M | -28.8M | -19.5M |
| EBITDA | - | -27.5M | -22.8M | -26.1M | -16.2M |
| Net Income | -24.6M | -26.9M | -21.7M | -28.7M | 5.30M |
| EPS | -0.13 | -0.14 | -0.06 | -0.07 | 0.01 |
| Balance Sheet | |||||
| Total Assets | 101M | 75.2M | 76.6M | 65.0M | 59.1M |
| Total Liabilities | 27.3M | 25.9M | 16.8M | 22.6M | 9.10M |
| Shareholders' Equity | 73.3M | 49.3M | 59.8M | 42.4M | 50.0M |
| Cash & Short-term Investments | 43.5M | 13.1M | 3.00M | 8.70M | 12.4M |
| Cash Flow | |||||
| Operating Cash Flow | -26.0M | -24.9M | -21.6M | -22.2M | -19.1M |
| Capital Expenditure | 6.12M | 3.30M | 1.60M | 400K | 900K |
| Free Cash Flow | -32.1M | -28.2M | -23.2M | -22.6M | -20.0M |
| Ratios | |||||
| ROE | -33.5% | -54.6% | -36.3% | -67.7% | 10.6% |
| ROA | -24.4% | -35.8% | -28.3% | -44.2% | 9.0% |
| Net Profit Margin | -97.8% | -98.9% | -542.5% | -717.5% | 88.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
CREO MEDICAL GRP LS-001 dividends
CREO MEDICAL GRP LS-001 has not paid dividends in the last 5 fiscal years.
Who owns CREO MEDICAL GRP LS-001
Ownership data of CREO MEDICAL GRP LS-001 is not available yet.
CREO MEDICAL GRP LS-001 company profile
- Company name
- CREO MEDICAL GRP LS-001
- Ticker
- 1RC.F
- ISIN
- GB00BZ1BLL44
- Exchange
- Frankfurt Exchange
- Sector
- -
- Industry
- -
- Fiscal year end
- December
- Address
- Website
- -